Exploiting the hallmarks of cancer
- 1 August 2003
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 39 (12) , 1668-1675
- https://doi.org/10.1016/s0959-8049(03)00273-9
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- The GH–IGF-I axis and breast cancerTrends in Endocrinology & Metabolism, 2003
- Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2New England Journal of Medicine, 2001
- Mammary gland specific hEGF receptor transgene expression induces neoplasia and inhibits differentiationOncogene, 2000
- Transforming growth factor alpha and mouse models of human breast cancerOncogene, 2000
- The Hallmarks of CancerCell, 2000
- Transgenic Mice Reveal Roles for TGFα and EGF Receptor in Mammary Gland Development and NeoplasiaJournal of Mammary Gland Biology and Neoplasia, 1997
- Insulin-like growth factors: the unrecognised oncogenesBritish Journal of Cancer, 1995
- IGF-1 Receptor as the Restriction Point of the Cell CycleAnnals of the New York Academy of Sciences, 1992
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1The Lancet, 1896